Frontiers in Transplantation | Immunosuppression

Original Research

Accepted on 05 Jan 2026

Does sex matter? - Longitudinal course and predictors of knowledge about immunosuppressant medication in patients after kidney transplantation: A KTx360° substudy

in Immunosuppression

Mariel Nöhre
Deborah Meier
Julia Talamo
Uwe Tegtbur
Lars Pape
Mario Schiffer
Martina De Zwaan

Frontiers in Transplantation

136 views

Brief Research Report

Published on 01 Dec 2025

Comparative evaluation of five tacrolimus assays in transplant recipients: implications for optimizing therapeutic drug monitoring

in Immunosuppression

Ivo N. SahBandar
Zhen Zhao
Sabrina E. Racine-Brzostek
Alex J. Rai
Maria Cid
Melissa M. Cushing
Neal Lindeman
Thangamani Muthukumar
He S. Yang

Frontiers in Transplantation

doi 10.3389/frtra.2025.1716789

892 views

Brief Research Report

Published on 14 May 2025

Incidence of catheter-related bloodstream infection (CRBSI) in immunosuppressed hosts post solid organ transplant (SOT): a single center experience

in Immunosuppression

Christopher El Mouhayyar
Ayman Al Jurdi
Kassem Safa

Frontiers in Transplantation

doi 10.3389/frtra.2025.1586035

2,632 views

Opinion

Published on 28 Mar 2025

The current issues of translating clinical xenokidney transplantation, with an emphasis on prevention of rejection

in Immunosuppression

Jean Kwun
Joseph M. Ladowski
Annette M. Jackson
Stuart Knechtle

Frontiers in Transplantation

doi 10.3389/frtra.2025.1559512

2,631 views
1 citation

Brief Research Report

Published on 16 Dec 2024

Immunoproteasome inhibition reduces donor specific antibody production and cardiac allograft vasculopathy in a mouse heart transplantation model

in Immunosuppression

Allison M. Schwalb
Imran Anwar
Isabel DeLaura
Joseph M. Ladowski
Janghoon Yoon
Rafaela Belloni
Mingqing Song
Carolyn Glass
Jun Wang
Stuart Knechtle

Frontiers in Transplantation

doi 10.3389/frtra.2024.1494455

1,816 views
1 citation

Original Research

Published on 25 Sep 2024

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response

in Immunosuppression

Moritz Anft
Panagiota Zgoura
Sarah Skrzypczyk
Michael Dürr
Richard Viebahn
Timm H. Westhoff
Ulrik Stervbo
Nina Babel

Frontiers in Transplantation

doi 10.3389/frtra.2024.1405070

2,248 views
1 citation

Brief Research Report

Published on 09 Sep 2024

Propionic acid supplementation promotes the expansion of regulatory T cells in patients with end-stage renal disease but not in renal transplant patients

in Immunosuppression

Moritz Anft
Fabian Meyer
Sirin Czygan
Felix S. Seibert
Benjamin J. Rohn
Fotios Tsimas
Richard Viebahn
Timm H. Westhoff
Ulrik Stervbo
Nina Babel

Frontiers in Transplantation

doi 10.3389/frtra.2024.1404740

2,172 views
2 citations

Editorial

Published on 10 Apr 2024

Editorial: Antibody-mediated rejection

in Immunosuppression

Ramsey R. Hachem
Thalachallour Mohanakumar

Frontiers in Transplantation

doi 10.3389/frtra.2024.1408225

1,493 views

Review

Published on 24 Jan 2024

BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients

in Immunosuppression

Sandesh Parajuli
Fahad Aziz
Weixiong Zhong
Arjang Djamali

Frontiers in Transplantation

doi 10.3389/frtra.2024.1309927

6,099 views
4 citations

Brief Research Report

Published on 11 Jan 2024

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression

in Immunosuppression

Jean L. Koff
Geeta M. Karadkhele
Jeffrey M. Switchenko
Manali Rupji
Kendra Little
Christian P. Larsen

Frontiers in Transplantation

doi 10.3389/frtra.2023.1280993

3,139 views
2 citations

Review

Published on 08 Dec 2023

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

in Immunosuppression

Corinne E. Praska
Riccardo Tamburrini
Juan Sebastian Danobeitia

Frontiers in Transplantation

doi 10.3389/frtra.2023.1277669

3,171 views
4 citations

Clinical Trial

Published on 21 Nov 2023

Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy

in Immunosuppression

Aurélie Philippe
Wolfgang Arns
Vanessa Ditt
Ingeborg A. Hauser
Friedrich Thaiss
Claudia Sommerer
Barbara Suwelack
Duska Dragun
Jan Hillen
Christiane Schiedel

Frontiers in Transplantation

doi 10.3389/frtra.2023.1273890

2,138 views
5 citations

Original Research

Published on 09 Nov 2023

Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells

in Immunosuppression

Shilei Xu
Sebastian Dolff
Nils Mülling
Hagen S. Bachmann
Yang Dai
Monika Lindemann
Ming Sun
Oliver Witzke
Andreas Kribben
Benjamin Wilde

Frontiers in Transplantation

doi 10.3389/frtra.2023.1233322

2,133 views
1 citation

Review

Published on 09 Nov 2023

The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction

in Immunosuppression

Wenbin Yang
Emilia Lecuona
Qiang Wu
Xianpeng Liu
Haiying Sun
Hasan Alam
Satish N. Nadig
Ankit Bharat

Frontiers in Transplantation

doi 10.3389/frtra.2023.1237671

2,408 views

Original Research

Published on 30 Oct 2023

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies

in Immunosuppression

Stephanie Ji
Hao Liu
Laura Pachella
Ryan D. Stephenson
Roman Groisberg
Sarah A. Weiss

Frontiers in Transplantation

doi 10.3389/frtra.2023.1284740

3,792 views
5 citations

Original Research

Published on 16 Oct 2023

Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring

in Immunosuppression

Arlisson Macedo Rodrigues
Mariana Tavares Tanno
Mariana Moraes Contti
Hong Si Nga
Mariana Farina Valiatti
Silvana Daher Costa
Tainá Veras de Sandes-Freitas
Ronaldo de Matos Esmeraldo
Camila Marinho Assunção
Juliana Bastos Campos Tassi

Frontiers in Transplantation

doi 10.3389/frtra.2023.1279940

2,134 views
2 citations

Review

Published on 29 Sep 2023

Management of donor-specific antibodies in lung transplantation

in Immunosuppression

William Brandon
Colin Dunn
Srinivas Bollineni
John Joerns
Adrian Lawrence
Manish Mohanka
Irina Timofte
Fernando Torres
Vaidehi Kaza

Frontiers in Transplantation

doi 10.3389/frtra.2023.1248284

5,211 views
4 citations

Original Research

Published on 04 Sep 2023

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients

in Immunosuppression

Sandhya Bansal
Ashwini Arjuna
Brian Franz
Alexa Guerrero-Alba
Jesse Canez
Timothy Fleming
Mohammad Rahman
Ramsey Hachem
T. Mohanakumar

Frontiers in Transplantation

doi 10.3389/frtra.2023.1248987

2,469 views
3 citations

Original Research

Published on 01 Sep 2023

Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model

in Immunosuppression

Robin Schmitz
Miriam Manook
Zachary Fitch
Imran Anwar
Isabel DeLaura
Danae Olaso
Ashley Choi
Janghoon Yoon
Yeeun Bae
Mingqing Song

Frontiers in Transplantation

doi 10.3389/frtra.2023.1230393

2,627 views
3 citations

Review

Published on 21 Aug 2023

Tacrolimus—why pharmacokinetics matter in the clinic

in Immunosuppression

Lino Henkel
Ulrich Jehn
Gerold Thölking
Stefan Reuter

Frontiers in Transplantation

doi 10.3389/frtra.2023.1160752

15,881 views
18 citations

Review

Published on 28 Apr 2023

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation

in Immunosuppression

Adriana Franco-Acevedo
Johanna Comes
Julia J. Mack
Nicole M. Valenzuela

Frontiers in Transplantation

doi 10.3389/frtra.2023.1146040

3,604 views
4 citations

Original Research

Published on 20 Apr 2023

Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus

in Immunosuppression

Emily A. Bosselmann
Fabian Dranicki
Alejandro Campos-Murguia
Björn Hartleben
Heiner Wedemeyer
Elmar Jaeckel
Richard Taubert

Frontiers in Transplantation

doi 10.3389/frtra.2023.1168163

3,826 views
1 citation

Perspective

Published on 19 Apr 2023

Translation of therapeutic strategies to modulate B cell reponses from non-human primate models to human kidney transplantation

in Immunosuppression

Stuart Knechtle
Jean Kwun
Shengli Song
Annette Jackson
Kitza Williams
Scott Sanoff

Frontiers in Transplantation

doi 10.3389/frtra.2023.1176796

1,781 views
1 citation

Original Research

Published on 22 Feb 2023

Impact of steroid withdrawal on subclinical graft injury after liver transplantation: A propensity score-matched cohort analysis

in Immunosuppression

Alejandro Campos-Murguia
Emily A. Bosselmann
Björn Hartleben
Heiner Wedemeyer
Bastian Engel
Richard Taubert
Elmar Jaeckel

Frontiers in Transplantation

doi 10.3389/frtra.2023.1124551

1,832 views

25 articles

articles

Does sex matter? - Longitudinal course and predictors of knowledge about immunosuppressant medication in patients after kidney transplantation: A KTx360° substudy

Comparative evaluation of five tacrolimus assays in transplant recipients: implications for optimizing therapeutic drug monitoring

Incidence of catheter-related bloodstream infection (CRBSI) in immunosuppressed hosts post solid organ transplant (SOT): a single center experience

The current issues of translating clinical xenokidney transplantation, with an emphasis on prevention of rejection

Immunoproteasome inhibition reduces donor specific antibody production and cardiac allograft vasculopathy in a mouse heart transplantation model

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response

Propionic acid supplementation promotes the expansion of regulatory T cells in patients with end-stage renal disease but not in renal transplant patients

Editorial: Antibody-mediated rejection

BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy

Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells

The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies

Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring

Management of donor-specific antibodies in lung transplantation

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients

Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model

Tacrolimus—why pharmacokinetics matter in the clinic

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation

Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus

Translation of therapeutic strategies to modulate B cell reponses from non-human primate models to human kidney transplantation

Impact of steroid withdrawal on subclinical graft injury after liver transplantation: A propensity score-matched cohort analysis